IgA Nephropathy
James V. Donadío, Joseph Peter Grande · New England Journal of Medicine · 2002
IgA nephropathy is the most common form of primary glomerulonephritis in the world and is also the most common cause of end-stage renal disease in patients with primary glomerulopathy. This article discusses current views on the pathogenesis, pathophysiology, clinical course, and treatment of this important glomerular disease. Although clinical trials have suggested that therapies such as glucocorticoids, n–3 fatty acids, and angiotensin-converting–enzyme inhibitors are efficacious, more definitive treatment is being sought.
Cited by 661 works. doi:10.1056/nejmra020109
Authors
References
- Corticosteroids in IgA nephropathy: a randomised controlled trial
- Predicting renal outcome in IgA nephropathy.
- A Controlled Trial of Fish Oil in IgA Nephropathy
- Prognostic Factors in Mesangial IgA Glomerulonephritis: An Extensive Study With Univariate and Multivariate Analyses
- Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease
- IgA nephropathy
- IgA nephropathy, the most common glomerulonephritis worldwide
- Epidemiology of primary glomerular diseases in a French region. Variations according to period and age
- IgA Nephropathy
- Henoch-Schönlein Purpura Nephritis